GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (FRA:J4D) » Definitions » Sale Of Investment

Kenvue (FRA:J4D) Sale Of Investment : €0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Kenvue Sale Of Investment?

Kenvue's sale of investment for the three months ended in Dec. 2024 was €0 Mil. It means Kenvue gained €0 Mil from selling investments. Kenvue's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €0 Mil.

Compared with last quarter (€0 Mil in Sep. 2024 ), Kenvue gained the same money from selling investments in Dec. 2024 (€0 Mil).

Kenvue Sale Of Investment Historical Data

The historical data trend for Kenvue's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kenvue Sale Of Investment Chart

Kenvue Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial - - - - -

Kenvue Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kenvue Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kenvue Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Kenvue's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Kenvue Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (FRA:J4D) » Definitions » Sale Of Investment
Comparable Companies
KMB CHD EL CLX CL HIMS COTY IPAR ELF NWL PG XPAR:OR LSE:ULVR BOM:500696 LSE:RKT XTER:HEN3 XTER:BEI TSE:4452 OSTO:ESSITY B TSE:8113
Traded in Other Exchanges
KVUE:USA KVUE:Mexico J4D:Germany
Address
199 Grandview Road, Skillman, NJ, USA, 08558
Website
https://www.kenvue.com
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Kenvue Headlines

No Headlines